Tolerogenic dendritic cells in autoimmune diseases. Crucial players in induction and prevention of autoimmunity

Autoimmunity Reviews

Volumn 10, Issue 1, 2010, Pages 8-17

  Torres Aguilar, Honorio ^a   Blank, Miri ^a   Jara, Luis J ^b,c   Shoenfeld, Yehuda ^a,d  

^a SHEBA MEDICAL CENTER   (Israel)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmune diseases; Dendritic cells; Tolerance

Indexed keywords

CALCITRIOL; COLONY STIMULATING FACTOR 1; DEXAMETHASONE; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 21; MYCOPHENOLIC ACID; SALICYLIC ACID DERIVATIVE; SCATTER FACTOR; THYMIC STROMAL LYMPHOPOIETIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANTINEOPLASTIC ACTIVITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; DENDRITIC CELL; GENETIC ENGINEERING; HUMAN; IMMUNOLOGICAL TOLERANCE; INFECTION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW;

AUTOIMMUNE DISEASES; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE;

EID: 78149361779     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.07.015     Document Type: Review

References (90)

1. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 2003, 21:685-711.
2. Dittel B.N., Visintin I., Merchant R.M., Janeway C.A. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J Immunol 1999, 163:32-39.
3. Tang J., Zhu W., Silver P.B., Su S.B., Chan C.C., Caspi R.R. Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. J Immunol 2007, 178:5578-5587.
4. Tamaki S., Homma S., Enomoto Y., Komita H., Zeniya M., Ohno T., et al. Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12. Clin Immunol 2005, 117:280-293.
5. Ludewig B., Odermatt B., Landmann S., Hengartner H., Zinkernagel R.M. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med 1998, 188:1493-1501.
6. Bayry J., Thirion M., Delignat S., Misra N., Lacroix-Desmazes S., Kazatchkine M.D., et al. Dendritic cells and autoimmunity. Autoimmun Rev 2004, 3:183-187.
7. Bondanza A., Zimmermann V.S., Dell'Antonio G., Dal Cin E., Capobianco A., Sabbadini M.G., et al. Dissociation between autoimmune response and clinical disease after vaccination with dendritic cells. J Immunol 2003, 170:24-27.
8. Shoenfeld Y., Blank M., Abu-Shakra M., Amital H., Barzilai O., Berkun Y., et al. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases. Isr Med Assoc J 2008, 10:13-19.
9. Shoenfeld Y., Zandman-Goddard G., Stojanovich L., Cutolo M., Amital H., Levy Y., et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases. Isr Med Assoc J 2008, 10:8-12.
10. Shoenfeld Y., Gilburd B., Abu-Shakra M., Amital H., Barzilai O., Berkun Y., et al. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases. Isr Med Assoc J 2008, 10:3-7.
11. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol 2002, 23:445-449.
12. Mahnke K., Schmitt E., Bonifaz L., Enk A.H., Jonuleit H. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol Cell Biol 2002, 80:477-483.
13. Randolph G.J., Ochando J., Partida-Sánchez S. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol 2008, 26:293-316.
14. Gallucci S., Lolkema M., Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999, 5:1249-1255.
15. Karni A., Abraham M., Monsonego A., Cai G., Freeman G.J., Hafler D., et al. Innate Immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J Immunol 2006, 177:4196-4202.
16. McMahon E.J., Bailey S.L., Miller S.D. CNS dendritic cells: critical participants in CNS inflammation?. Neurochem Int 2006, 49:195-203.
17. Santiago-Schwarz F. Dendritic cells: friend or foe in autoimmunity?. Rheum Dis Clin North Am 2004, 30:115-134.
18. Roelofs M.F., Joosten L.A., Abdollahi-Roodsaz S., van Lieshout A.W., Sprong T., van den Hoogen F.H., et al. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum 2005, 52:2313-2322.
19. Ding D., Mehta H., McCune W.J., Kaplan M.J. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J Immunol 2006, 177(9):5878-5889.
20. Means T.K., Latz E., Hayashi F., Murali M.R., Golenbock D.T., Luster A.D. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 2005, 115:407-417.
21. Jara L.J., Benitez G., Medina G. Prolactin, dendritic cells, and systemic lupus erythematosus. Autoimmun Rev 2008, 7:251-255.
22. O'Doherty U., Pengs M., Gezelter S., Swiggard W.J., Betjes M., Bhardwaj N., et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994, 82:487-493.
23. Dzionek A., Fuchs A., Schmidt P., Cremer S., Zysk M., Miltenyi S., et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of blood dendritic cells in human peripheral. J Immunol 2000, 165:6037-6046.
24. Liu Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005, 23:275-306.
25. Morelli A., Rubin J., Erdos G., Tkacheva O., Mathers A., Zahorchak A., et al. CD4+ T cell responses elicited by different subsets of human skin migratory dendritic cells. J Immunol 2005, 175:7905-7915.
26. Nestle F.O., Conrad C., Tun-Kyi A., Homey B., Gombert M., Boyman O., et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 2005, 202:135-143.
27. McGregor J.M., Barker J.N., Ross E.L., MacDonald D.M. Epidermal dendritic cells in psoriasis possess a phenotype associated with antigen presentation: in situ expression of beta 2-integrins. J Am Acad Dermatol 1992, 27:383-388.
28. Lowes M.A., Chamian F., Abello M.V., Fuentes-Duculan J., Lin S.L., Nussbaum R., et al. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci USA 2005, 102:19057-19062.
29. Allen C.D., Cyster J.G. Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. Semin Immunol 2008, 20:14-25.
30. Ozaki Y., Amakawa R., Ito T., Iwai H., Tajima K., Uehira K., et al. Alteration of peripheral blood dendritic cells in patients with primary Sjögren's syndrome. Arthritis Rheum 2001, 44:419-431.
31. Amft N., Bowman S.J. Chemokines and cell trafficking in Sjogren's syndrome. Scand J Immunol 2001, 54:62-69.
32. Gottenberg J.E., Cagnard N., Lucchesi C., Letourneur F., Mistou S., Lazure T., et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc Natl Acad Sci USA 2006, 103:2770-2775.
33. Kyewski B., Derbinski J. Self-representation in the thymus: an extended view. Nat Rev Immunol 2004, 4:688-698.
34. Fairchild P.J., Austyn J.M. Thymic dendritic cells: phenotype and function. Int Rev Immunol 1990, 6:187-196.
35. Sakaguchi N., Takahashi T., Hata H., Nomura T., Tagami T., et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003, 426:454-460.
36. Lo J., Clare-Salzler M.J. Dendritic cell subsets and type I diabetes: focus upon DC-based therapy. Autoimmun Rev 2006, 5:419-423.
37. Jones E.Y., Fugger L., Strominger J.L., Siebold C. MHC class II proteins and disease: a structural perspective. Nat Rev Immunol 2006, 6:271-282.
38. Walker L.S., Abbas A.K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2002, 2:11-19.
39. Schwartz R.H. T cell anergy. Annu Rev Immunol 2003, 21:305-334.
40. Suss G., Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med 1996, 183:1789-1796.
41. Zhang J., Xu X., Liu Y. Activation-induced cell death in T cells and autoimmunity. Cell Mol Immunol 2004, 1:186-192.
42. Kubsch S., Graulich E., Knop J., Steinbrink K. Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1. Eur J Immunol 2003, 33:1988-1997.
43. Muñoz L.E., Peter C., Herrmann M., Wesselborg S., Lauber K. Scent of dying cells: the role of attraction signals in the clearance of apoptotic cells and its immunological consequences. Autoimmun Rev 2010, 9:425-430.
44. Janko C., Schorn C., Grossmayer G.E., Frey B., Herrmann M., Gaipl U.S., et al. Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE). Autoimmun Rev 2008, 8:9-12.
45. Feili-Hariri M., Falkner D.H., Morel P.A. Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice. Eur J Immunol 2002, 32:2021-2030.
46. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007, 13:139-145.
47. Afzali B., Lombardi G., Lechler R.I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007, 148:32-46.
48. Crispin J.C., Alcocer-Varela J. The role myeloid dendritic cells play in the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 2007, 6:450-456.
49. Karni A., Abraham M., Monsonego A., Cai G., Freeman G.J., Hafler D., et al. Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J Immunol 2006, 177:4196-4202.
50. Marleau A.M., Singh B. Myeloid dendritic cells in non-obese diabetic mice have elevated costimulatory and T helper-1-inducing abilities. J Autoimmun 2002, 19:23-35.
51. Zaba L.C., Fuentes-Duculan J., Eungdamrong N.J., Abello M.V., Novitskaya I., Pierson K.C., et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 2009, 129:79-88.
52. Costantino C.M., Baecher-Allan C.M., Hafler D.A. Human regulatory T cells and autoimmunity. Eur J Immunol 2008, 38:921-924.
53. Lan R.Y., Ansari A.A., Lian Z.X., Gershwin M.E. Regulatory T cells: development, function and role in autoimmunity. Autoimmun Rev 2005, 4:351-363.
54. Torgerson T.R. Regulatory T cells in human autoimmune diseases. Springer Semin Immunopathol 2006, 28:63-76.
55. Sansonetti P.J. War and peace at mucosal surfaces. Nat Rev Immunol 2004, 4:953-964.
56. Silva M.A. Intestinal dendritic cells and epithelial barrier dysfunction in Crohn's disease. Inflamm Bowel Dis 2009, 15:436-453.
57. Liang X., Ma L., Thai N.L., Fung J.J., Qian S., Lu L. The role of liver-derived regulatory dendritic cells in prevention of type 1 diabetes. Immunology 2007, 120:251-260.
58. Miwa N., Hayakawa S., Miyazaki S., Myojo S., Sasaki Y., Sakai M., et al. IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion. Mol Hum Reprod 2005, 11:865-870.
59. Shoenfeld Y., Blank M. The infectious etiology of the antiphospholipid syndrome (APS). Autoimmun Rev 2004, 3(Suppl 1):S32-S34.
60. Dechend R., Müller D.N., Wallukat G., Homuth V., Krause M., Dudenhausen J., et al. Activating auto-antibodies against the AT1 receptor in preeclampsia. Autoimmun Rev 2005, 4:61-65.
61. Huang Q., Liu D., Majewski P., Schulte L.C., Korn J.M., Young R.A., et al. The plasticity of dendritic cell responses to pathogens and their components. Science 2001, 294:870-875.
62. Israeli E., Agmon-Levin N., Blank M., Shoenfeld Y. Adjuvants and autoimmunity. Lupus 2009, 18:1217-1225.
63. Blank M., Barzilai O., Shoenfeld Y. Molecular mimicry and auto-immunity. Clin Rev Allergy Immunol 2007, 32:111-118.
64. Rose N.R. Infections, mimics, and autoimmune disease. J Clin Invest 2001, 107:943-944.
65. Ram M., Shoenfeld Y. Harnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality?. Ann NY Acad Sci 2007, 1110:410-425.
66. Engelhorn M.E. Autoimmunity and tumor immunity induced by immune responses to mutations in self. Nat Med 2006, 12:198-206.
67. Piemonti L., Monti P., Allavena P., Sironi P., Soldini M., Leone L., et al. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 1999, 162:6473-6481.
68. Penna G., Adorini L. 1 alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000, 164:2405-2411.
69. Hackstein H., Morelli A.E., Larregina A.T., Ganster R.W., Papworth G.D., Logar A.J., et al. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J Immunol 2001, 166:7053-7062.
70. Mehling A., Grabbe S., Voskort M., Schwarz T., Luger T.A., Beissert S. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J Immunol 2000, 165:2374-2381.
71. Steinbrink K., Wolfl M., Jonuleit H., Knop J., Enk A.H. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997, 159:4772-4780.
72. Sato K., Yamashita N., Baba M., Matsuyama T. Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 2003, 101:3581-3589.
73. Menges M., Rossner S., Voigtländer C., Schindler H., Kukutsch N.A., Bogdan C., et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 2002, 195:15-21.
74. Li G., Kim Y.J., Broxmeyer H.E. Macrophage colony-stimulating factor drives cord blood monocyte differentiation into IL-10(high)IL-12absent dendritic cells with tolerogenic potential. J Immunol 2005, 174:4706-4717.
75. Rutella S., Bonanno G., Procoli A., Mariotti A., de Ritis D.G., Curti A., et al. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. Blood 2006, 108:218-227.
76. Brandt K., Bulfone-Paus S., Foster D.C., Ruckert R. Interleukin-21 inhibits dendritic cell activation and maturation. Blood 2003, 102:4090-4098.
77. Watanabe N., Wang Y.H., Lee H.K., Ito T., Wang Y.H., Cao W., et al. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005, 436:1181-1185.
78. Gonzalez-Rey E., Chorny A., Fernandez-Martin A., Ganea D., Delgado M. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. Blood 2006, 107:3632-3638.
79. Bayry J., Lacroix-Desmazes S., Carbonneil C., Misra N., Donkova V., Pashov A., et al. Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood 2003, 101:758-765.
80. Ma L., Qian S., Liang X., Wang L., Woodward J.E., Giannoukakis N., et al. Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity. Diabetes 2003, 52:1976-1985.
81. Lu L., Lee W.C., Takayama T., Qian S., Gambotto A., Robbins P.D., et al. Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-beta, and CTLA4Ig). J Leukoc Biol 1999, 66:293-296.
82. Lakkis F.G., Sayegh M.H. Memory T cells: a hurdle to immunologic tolerance. J Am Soc Nephrol 2003, 14:2402-2410.
83. Jenkins M. Memory and anergy: challenges to traditional T lymphocyte differentiation. FASEB J 1992, 6:2428-2433.
84. Walker L.S., Abbas A.K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2002, 2:11-19.
85. Petersen L.D., Duinkerken G., Bruining G.J., van Lier R.A., de Vries R.R., Roep B.O. Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus. J Autoimmun 1996, 9:731-737.
86. MarttilaJ H.S., Vaarala O., Suzyki K., Elliott J.F., Narvanen A., Knip M., et al. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type t diabetes or multiple beta-cell autoantibodies. J Autoimmun 2008, 31:142-148.
87. Torres-Aguilar H., Aguilar-Ruiz S.R., González-Pérez G., Munguía R., Bajaña S., Meraz-Ríos M.A., et al. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J Immunol 2010, 184:1765-1775.
88. Torres-Aguilar H, Sánchez-Torres C, Jara LJ, Blank M, Shoenfeld Y. IL-10/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector/memory t cells from type 1 diabetic individuals. J Clin Immunol. 2010 [in printing].
89. Yona S., Jung S. Monocytes: subsets, origins, fates and functions. Curr Opin Hematol 2010, 17(1):53-59.
90. Geissmann F., Auffray C., Palframan R., Wirrig C., Ciocca A., Campisi L., et al. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol 2008, 86:398-408.